ID   Fitz-HSA
AC   CVCL_1R34
SY   FITZ-HSA; FITZ; Fitz; DEN-HSA/Fitz; HSA-Fitz
DR   BioSample; SAMN03151633
DR   GEO; GSM1974788
DR   Wikidata; Q54834943
RX   PubMed=17338158;
RX   PubMed=21908323;
RX   PubMed=22594682;
RX   PubMed=22849686;
RX   PubMed=27197945;
RX   PubMed=30601866;
WW   https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a DEN-HSA derivative (PubMed=21908323).
CC   Part of: FACC canine tumor cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00400.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Golden Retriever.
ST   Source(s): PubMed=27197945
ST   Dog FHC2010: 231,235
ST   Dog FHC2054: 168,172
ST   Dog FHC2079: 275,279
ST   Dog PEZ1: 115,123
ST   Dog PEZ3: 119,121
ST   Dog PEZ5: 103
ST   Dog PEZ6: 183
ST   Dog PEZ8: 228,240
ST   Dog PEZ12: 285,288
ST   Dog PEZ20: 176,180
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_1R33 ! DEN-HSA
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 15
//
RX   PubMed=17338158; DOI=10.1111/j.1939-1676.2007.tb02936.x;
RA   U'Ren L.W., Biller B.J., Elmslie R.E., Thamm D.H., Dow S.W.;
RT   "Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.";
RL   J. Vet. Intern. Med. 21:113-120(2007).
//
RX   PubMed=21908323; DOI=10.1177/1040638711408064;
RA   O'Donoghue L.E., Rivest J.P., Duval D.L.;
RT   "Polymerase chain reaction-based species verification and
RT   microsatellite analysis for canine cell line validation.";
RL   J. Vet. Diagn. Invest. 23:780-785(2011).
//
RX   PubMed=22594682; DOI=10.1111/j.1476-5829.2012.00335.x;
RA   Lyles S.E., Milner R.J., Kow K., Salute M.E.;
RT   "In vitro effects of the tyrosine kinase inhibitor, masitinib
RT   mesylate, on canine hemangiosarcoma cell lines.";
RL   Vet. Comp. Oncol. 10:223-235(2012).
//
RX   PubMed=22849686; DOI=10.2460/ajvr.73.8.1252;
RA   Urbasic A.S., Hynes S., Somrak A.J., Contakos S., Rahman M.M., Liu J.,
RA   MacNeill A.L.;
RT   "Oncolysis of canine tumor cells by myxoma virus lacking the serp2
RT   gene.";
RL   Am. J. Vet. Res. 73:1252-1261(2012).
//
RX   PubMed=27197945; DOI=10.1111/vco.12192;
RA   Fowles J.S., Dailey D.D., Gustafson D.L., Thamm D.H., Duval D.L.;
RT   "The Flint Animal Cancer Center (FACC) canine tumour cell line panel:
RT   a resource for veterinary drug discovery, comparative oncology and
RT   translational medicine.";
RL   Vet. Comp. Oncol. 15:481-492(2017).
//
RX   PubMed=30601866; DOI=10.1371/journal.pone.0210297;
RA   Dowling M., Samuelson J., Fadl-Alla B., Pondenis H.C., Byrum M.,
RA   Barger A.M., Fan T.M.;
RT   "Overexpression of prostate specific membrane antigen by canine
RT   hemangiosarcoma cells provides opportunity for the molecular detection
RT   of disease burdens within hemorrhagic body cavity effusions.";
RL   PLoS ONE 14:E0210297-E0210297(2019).
//